UL Q1 2026

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Earnings

Unilever's first quarter of 2026 arrives against a backdrop of mounting investor skepticism, with analysts eyeing the consumer goods giant's $12.45 billion revenue consensus estimate as a critical test of whether the company can sustain momentum foll… Read more Unilever's first quarter of 2026 arrives against a backdrop of mounting investor skepticism, with analysts eyeing the consumer goods giant's $12.45 billion revenue consensus estimate as a critical test of whether the company can sustain momentum following its ice cream business spin-off. The March filing of Unilever's 2025 Annual Report on Form 20-F offered little in the way of quarterly detail, confirming only that full-year 2025 sales reached $50.50 billion across a portfolio spanning Beauty & Wellbeing, Personal Care, Home Care, and Foods, sold in over 190 countries to roughly 3.7 billion consumers daily. No forward-looking financial guidance accompanied the filing, leaving investors to weigh Unilever's trajectory against a challenging macro environment, where surging oil prices have renewed concerns about input cost pressures and the company's ability to drive genuine volume growth rather than price-led gains. Shares have reflected that unease, sliding sharply in recent weeks as analysts question whether the company's 2026 growth and margin targets remain within reach.